Non-alcoholic fatty liver disease occurs in most obese people, the main pathway of which is the process of fibrogenesis. This disorder is currently classified into two types: hepatic steatosis and nonalcoholic steatohepatitis. Hepatic steatosis is a reversible condition in which large vacuoles of triglyceride fat accumulate in the liver cells, causing nonspecific inflammation. Most people with this condition experience few, if any, symptoms, and it does not usually lead to scarring or serious liver damage. The majority of patients with nonalcoholic fatty liver disease have this type. Nonalcoholic steatohepatitis is the more severe, progressive form that involves not only fat accumulation (steatosis) in the liver but also inflammation. Steat...
PURPOSE: In morbid obesity nonalcoholic fatty liver disease (NAFLD) is endemic. Aim of this study is...
Currently nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are medic...
The present review highlights the new diagnostic tools for detecting hepatic fibrosis against the ba...
Non-alcoholic fatty liver disease occurs in most obese people, the main pathway of which is the proc...
Non-alcoholic fatty liver disease occurs in most obese people, the main pathway of which is the proc...
Background. The prevalence of obesity among children has become a global epidemic today. The importa...
Background. Nonalcoholic fatty liver disease (NAFLD) includes a spectrum of diseases associated with...
An increasing percentage of people have or are at risk to develop non-alcoholic fatty liver disease ...
Introduction. Nonalcoholic fatty liver disease (NAFLD) is considered as one of the most common chro...
OBJECTIVE. To identify clinical, socio-demographic, dietary and biological markers to be used in a n...
Only some individuals with obesity develop liver fibrosis due to non-alcoholic fatty liver disease (...
The term "non-alcoholic fatty liver disease" (NAFLD) encompasses a wide range of pathological condit...
The aim of the work is to investigate the diagnostic value of laboratory blood biomarkers – alanine ...
Excess collagen synthesis (fibrogenesis) in the liver plays a causal role in the progression of nona...
Introduction/aims: Liver fibrosis assessment is a key issue in the evaluation of nonalcoholic fatty ...
PURPOSE: In morbid obesity nonalcoholic fatty liver disease (NAFLD) is endemic. Aim of this study is...
Currently nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are medic...
The present review highlights the new diagnostic tools for detecting hepatic fibrosis against the ba...
Non-alcoholic fatty liver disease occurs in most obese people, the main pathway of which is the proc...
Non-alcoholic fatty liver disease occurs in most obese people, the main pathway of which is the proc...
Background. The prevalence of obesity among children has become a global epidemic today. The importa...
Background. Nonalcoholic fatty liver disease (NAFLD) includes a spectrum of diseases associated with...
An increasing percentage of people have or are at risk to develop non-alcoholic fatty liver disease ...
Introduction. Nonalcoholic fatty liver disease (NAFLD) is considered as one of the most common chro...
OBJECTIVE. To identify clinical, socio-demographic, dietary and biological markers to be used in a n...
Only some individuals with obesity develop liver fibrosis due to non-alcoholic fatty liver disease (...
The term "non-alcoholic fatty liver disease" (NAFLD) encompasses a wide range of pathological condit...
The aim of the work is to investigate the diagnostic value of laboratory blood biomarkers – alanine ...
Excess collagen synthesis (fibrogenesis) in the liver plays a causal role in the progression of nona...
Introduction/aims: Liver fibrosis assessment is a key issue in the evaluation of nonalcoholic fatty ...
PURPOSE: In morbid obesity nonalcoholic fatty liver disease (NAFLD) is endemic. Aim of this study is...
Currently nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are medic...
The present review highlights the new diagnostic tools for detecting hepatic fibrosis against the ba...